See also this year's filing and all EDGAR filings for this company.
PDF Report 0001621221_2022_ARTELO_BIOSCIENCES_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001621221')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001621221, ARTELO BIOSCIENCES INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 10,317,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,039,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 279,000 |
| 4 | LiabilitiesCurrent | 526,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 67,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,521,000 |
| 9 | ResearchAndDevelopmentExpense | 2,839,000 |
| 10 | remainder_Expenses | 1,081,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -7,437,000 |
| 13 | remainder_ComprehensiveNetIncome | -46,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,635,000 |
| 1 | Liabilities | 593,000 |
| 2 | Expenses | 7,441,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 12,042,000 |
| 5 | NetIncome | -14,878,000 |
| 6 | ComprehensiveNetIncome | -14,901,000 |
| 7 | BaseVar | 14,076,000 |
| 8 | EconomicCapitalRatio | 0.879 |
Edgar->Model Mapping
Feature Distribution
Change over Time
